Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention.
Hun-Tae KimJung Hee LeeJong Ho NamChan-Hee LeeJang-Won SonWoong KimJong-Seon ParkDong-Gu ShinPublished in: Yonsei medical journal (2022)
Although extended DAPT led to a reduction in MACCEs in non-anemic patients, it was related to increased major bleeding without reducing MACCEs in anemic patients.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- end stage renal disease
- chronic kidney disease
- acute coronary syndrome
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- coronary artery disease
- acute myocardial infarction
- heart failure
- atrial fibrillation
- st segment elevation myocardial infarction
- patient reported outcomes